Keywords: Eisai, Perampanel, Epilepsy, Zonagran, Europe, USA

Eisai epilepsy drug delayed by US FDA, but Zonegran use extension filing accepted in EU

Article | 01 August 2011

Print This

There was disappointment for Japanese drug major Eisai (TYO: 4523) last week when the US Food and Drug Administration has issued ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in